| GC32629-20mg |
|
152802-84-1 |
|
0 |
C15H14ClN5 |
|
|
|
| GC32629-10mg |
|
152802-84-1 |
|
0 |
C15H14ClN5 |
|
|
|
| GC32629-5mg |
|
152802-84-1 |
|
0 |
C15H14ClN5 |
|
|
|
| GC32629-1mg |
|
152802-84-1 |
|
0 |
C15H14ClN5 |
|
|
|
| GC32627-1mg |
|
86484-91-5 |
Dopexamine hydrochloride (FPL60278AR)
|
0 |
C22H34Cl2N2O2 |
|
|
|
| GC32626-50mg |
|
61596-47-2 |
Prolylleucine (((Benzyloxy)carbonyl)-L-prolyl-D-leucine)
|
0 |
C19H26N2O5 |
|
|
|
| GC32626-25mg |
|
61596-47-2 |
Prolylleucine (((Benzyloxy)carbonyl)-L-prolyl-D-leucine)
|
0 |
C19H26N2O5 |
|
|
|
| GC32626-10mg |
|
61596-47-2 |
Prolylleucine (((Benzyloxy)carbonyl)-L-prolyl-D-leucine)
|
0 |
C19H26N2O5 |
|
|
|
| GC32626-10mM(1mLinDMSO) |
|
61596-47-2 |
Prolylleucine (((Benzyloxy)carbonyl)-L-prolyl-D-leucine)
|
0 |
C19H26N2O5 |
|
|
|
| GC32625-20mg |
|
408502-06-7 |
|
0 |
C23H25N3O3 |
|
|
|
| GC32625-10mg |
|
408502-06-7 |
|
0 |
C23H25N3O3 |
|
|
|
| GC32625-5mg |
|
408502-06-7 |
|
0 |
C23H25N3O3 |
|
|
|
| GC32625-1mg |
|
408502-06-7 |
|
0 |
C23H25N3O3 |
|
|
|
| GC32624-10mg |
|
3447-95-8 |
Benzofurodil (Benfurodil)
|
0 |
C19H18O7 |
|
|
|
| GC32624-5mg |
|
3447-95-8 |
Benzofurodil (Benfurodil)
|
0 |
C19H18O7 |
|
|
|
| GC32624-1mg |
|
3447-95-8 |
Benzofurodil (Benfurodil)
|
0 |
C19H18O7 |
|
|
|
| GC32622-5mg |
|
154765-05-6 |
Adrenomedullin (AM) (13-52), human
|
0 |
C200H308N58O59S2 |
|
|
|
| GC32622-1mg |
|
154765-05-6 |
Adrenomedullin (AM) (13-52), human
|
0 |
C200H308N58O59S2 |
|
|
|
| GC32621-20mg |
|
13460-98-5 |
Theodrenaline ((±)?-?Theodrenaline)
|
0 |
C17H21N5O5 |
|
|
|
| GC32621-10mg |
|
13460-98-5 |
Theodrenaline ((±)?-?Theodrenaline)
|
0 |
C17H21N5O5 |
|
|
|
